Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models

The goal of this study was to examine the effects of xyloketal B on nonalcoholic fatty liver disease (NAFLD) and to explore the molecular mechanisms underlying its effects in both in vivo and in vitro models. We discovered an association between xyloketal B and the sterol regulatory element-binding...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Youying, Meng, Tian, Zuo, Ling, Bei, Yu, Zhang, Qihao, Su, Zhijian, Huang, Yadong, Pang, Jiyan, Xiang, Qi, Yang, Hongtu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484113/
https://www.ncbi.nlm.nih.gov/pubmed/28587208
http://dx.doi.org/10.3390/md15060163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484113/
https://www.ncbi.nlm.nih.gov/pubmed/28587208
http://dx.doi.org/10.3390/md15060163

Ejemplares similares